Advertisement
Screener

NEUROCRINE BIOSCIENCES INC (NBIX) Pre-Tax Margin

NEUROCRINE BIOSCIENCES INC (NBIX) Pre-Tax Margin

  • 2026-06-30: Pre-Tax Margin 16.91%.
  • 2026-03-31: Pre-Tax Margin 30.30%.
  • 2025-12-31: Pre-Tax Margin 29.72%.
  • 2025-09-30: Pre-Tax Margin 36.71%.

Complete source-backed pre-tax margin history.

Available history
2016-12-31 to 2026-06-30
Data captured

Historical Pre-Tax Margin

DatePre-Tax Margin
2026-06-3016.91%
2026-03-3130.30%
2025-12-3129.72%
2025-09-3036.71%
2025-06-3023.20%
2025-03-312.57%
2024-12-3125.90%
2024-09-3030.59%
2024-06-3016.71%
2024-03-316.70%
2023-12-3138.47%
2023-09-3023.18%
2023-06-3026.86%
2023-03-31-24.57%
2022-12-3128.62%
2022-09-3025.24%
2022-06-30-6.16%
2022-03-316.89%
2021-12-31-4.42%
2021-09-3010.30%
2021-06-3019.90%
2021-03-3111.50%
2020-12-3116.82%
2020-09-30-22.09%
2020-06-3027.51%
2020-03-3116.41%
2019-12-3115.81%
2019-09-3026.29%
2019-06-3028.39%
2019-03-31-74.13%
2018-12-3114.28%
2018-09-3033.45%
2018-06-30-6.10%
2018-03-31-58.83%

Annual Pre-Tax Margin

DatePre-Tax Margin
2025-12-3124.66%
2024-12-3120.63%
2023-12-3117.60%
2022-12-3114.37%
2021-12-318.95%
2020-12-3110.20%
2019-12-315.90%
2018-12-314.83%
2017-12-31-88.19%
2016-12-31-940.60%

Similar stocks

Stock NameCountryMarket CapPE Ratio
EXELIXIS, INC. (EXEL)United States$14.358B16.15
HALOZYME THERAPEUTICS, INC. (HALO)United States$13.083B21.59
Twist Bioscience Corp (TWST)United States$11.540B-47.21
BIO-TECHNE Corp (TECH)United States$11.379B74.68
REPLIGEN CORP (RGEN)United States$10.755B185.31
Krystal Biotech, Inc. (KRYS)United States$10.210B45.56
Kymera Therapeutics, Inc. (KYMR)United States$9.631B-31.69
ImmunityBio, Inc. (IBRX)United States$9.157B-9.29
Vaxcyte, Inc. (PCVX)United States$8.466B-7.91
Immunovant, Inc. (IMVT)United States$7.028B-14.78